Offer - Urjas Oil for just ₹ 1 X
Olkem Trio 6.25 Tablet is a prescription medicine that is available as a Tablet. Other than this, Olkem Trio 6.25 Tablet has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Olkem Trio 6.25 Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Olkem Trio 6.25 Tablet include Upper respiratory tract infection, Loss of appetite, Gastric Irritation. Apart from the aforementioned side effects, Olkem Trio 6.25 Tablet can also lead to other problems, which have been listed below. Such side effects of Olkem Trio 6.25 Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Olkem Trio 6.25 Tablet's effect during pregnancy is Mild and Mild while nursing. In addition, Olkem Trio 6.25 Tablet's effects on the liver, heart and kidney are discussed below in the Olkem Trio 6.25 Tablet related warnings section.
Olkem Trio 6.25 Tablet is contraindicated in people with pre-existing medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension) as it can result in adverse effects. Other conditions have been mentioned below in the Olkem Trio 6.25 Tablet contraindications section.
Additionally, Olkem Trio 6.25 Tablet may also adversely react with other medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Olkem Trio 6.25 Tablet is considered not safe while driving, and is not addictive.
Olkem Trio 6.25 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olkem Trio 6.25 Tablet safe for pregnant women?
Pregnant women may get mild side effects from Olkem Trio.
Is the use of Olkem Trio 6.25 Tablet safe during breastfeeding?
Olkem Trio has been seen to have minimal side effects on breastfeeding women.
What is the effect of Olkem Trio 6.25 Tablet on the Kidneys?
Olkem Trio rarely harms the kidneys.
What is the effect of Olkem Trio 6.25 Tablet on the Liver?
Olkem Trio may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Olkem Trio 6.25 Tablet on the Heart?
Olkem Trio has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Olkem Trio 6.25 Tablet unless your doctor advises you to do so -
Is this Olkem Trio 6.25 Tablet habit forming or addictive?
No, there is no any evidence that Olkem Trio 6.25 Tablet is addictive.
Interaction between Food and Olkem Trio 6.25 Tablet
Taking Olkem Trio 6.25 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Olkem Trio 6.25 Tablet
Consult your doctor before consuming alcohol while taking Olkem Trio 6.25 Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448